A Study of EXG102-031 in Patients With wAMD (Everest)
NCT05903794
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular (Wet) Age-related Macular Degeneration (nAMD)
Interventions
BIOLOGICAL:
EXG102-031
Sponsor
Exegenesis Bio